Advanced company searchLink opens in new window

COSYNE THERAPEUTICS LIMITED

Company number 13171951

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
25 Oct 2024 SH08 Change of share class name or designation
21 Oct 2024 SH01 Statement of capital following an allotment of shares on 8 August 2024
  • GBP 63.69135
19 Oct 2024 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES12 ‐ Resolution of varying share rights or name
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
19 Oct 2024 MA Memorandum and Articles of Association
09 Oct 2024 AP01 Appointment of Gillian Cannon as a director on 22 July 2024
24 May 2024 AA Total exemption full accounts made up to 29 February 2024
15 Feb 2024 CS01 Confirmation statement made on 31 January 2024 with updates
01 Sep 2023 RESOLUTIONS Resolutions
  • RES13 ‐ Transfer of shares 28/02/2023
24 Aug 2023 SH01 Statement of capital following an allotment of shares on 7 August 2023
  • GBP 54.00999
06 Jul 2023 SH08 Change of share class name or designation
27 Jun 2023 MA Memorandum and Articles of Association
27 Jun 2023 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES12 ‐ Resolution of varying share rights or name
  • RES01 ‐ Resolution of adoption of Articles of Association
13 Jun 2023 TM01 Termination of appointment of Michael Johnson as a director on 19 May 2023
02 Jun 2023 AA Total exemption full accounts made up to 28 February 2023
07 Feb 2023 CS01 Confirmation statement made on 31 January 2023 with updates
07 Feb 2023 CH01 Director's details changed for Dr Louwai Muhammed on 30 January 2023
07 Sep 2022 PSC08 Notification of a person with significant control statement
07 Sep 2022 PSC07 Cessation of Michael Johnson as a person with significant control on 16 May 2022
06 Sep 2022 PSC07 Cessation of Louwai Muhammed as a person with significant control on 16 May 2022
06 Sep 2022 PSC07 Cessation of Liisi Laaniste as a person with significant control on 16 May 2022
22 Aug 2022 AA Total exemption full accounts made up to 28 February 2022
04 Aug 2022 SH01 Statement of capital following an allotment of shares on 20 May 2022
  • GBP 53.0521
07 Jun 2022 MA Memorandum and Articles of Association
07 Jun 2022 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES01 ‐ Resolution of adoption of Articles of Association
12 May 2022 MA Memorandum and Articles of Association